InvestorsHub Logo
Followers 12
Posts 1261
Boards Moderated 0
Alias Born 04/12/2011

Re: MastersN post# 904

Friday, 08/04/2017 3:21:38 PM

Friday, August 04, 2017 3:21:38 PM

Post# of 1064
They've got a promising tech ( CAR-T) involving tailoring immune cells to attack cancers..A lot like KITE's .Good clinical trial results propelled them.
Typically, the price on these stocks sinks between positive news announcements....Assuming they are positive. Cancer cures face long odds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PACB News